l-carnitine type 2 diabetes Risks and benefits of carnitine supplementation in L-Carnitine – DR MARTIN'S NUTRITION

Description

Back to Archived Journals Research and Reports in Neonatology Volume 6 Screening for medium-chain acyl CoA dehydrogenase deficiency: current perspectives Authors Soler-Alfonso C, Bennett M, Ficicioglu C Received 3 June 2015 Accepted for publication 16 September 2015 Published 18 January 2016 Volume 2016:6 Pages 110 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 5 Editor who approved publication: Dr Robert Schelonka Claudia Soler-Alfonso, 1 Michael J Bennett, 2 Can Ficicioglu 1 1 Department of Pediatrics, Section of Metabolic Disease, 2 Department of Pathology and Laboratory Medicine, The Childrens Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA Abstract: Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is the most common disorder associated with fatty acid oxidation

One series found thalamic diffusion restriction in half of the patients with focal-onset status epilepticus

Aging Cell 22 , e13770 (2023)

Hepatic glucokinase expression is associated with lipogenesis and fatty liver in humans

[DOI] [PMC free article] [PubMed] [Google Scholar] 4.Shug AL & Keene BW (1989) Method for preventing diet induced carnitine deficiency in domesticated dogs and cats